Sponsors & Exhibitors | Orphan Drugs and Rare Diseases 2021
Sponsors & Exhibitors
Durbin is one of the leading providers of comparator sourcing and managed access programs to pharmaceutical and biotech companies around the world. In its 55th year of business, Durbin is pleased to look back on a history of sourcing pharmaceuticals for physicians and patients around the world and even in 3rd world countries, providing urgent and cost effective supply of pharmaceuticals to global charity and relief organizations and of course its pharmaceutical services division who source and distribute comparator drugs for clinical trials and run managed access programs that provide access to needed pharmaceuticals in non-approved markets. Durbin’s distribution network includes regular shipments to over 180 countries globally. Their managed access programs include orphan, gene, and controlled products. Durbin has full service offices in the United Kingdom, European Union and United States.
Illingworth Research Group is a provider of patient centric clinical research solutions. Services are tailored to clinical requirements but can include: mobile research nursing, patient concierge and medical photography, for example. These services are operational in 45 countries and concentrate on taking the trail to the patient or making trial participation easier and more accessible to patients and their families.
Patient centricity is a vital part of our mission and has been so for 20 years. Our Research Nursing support focuses on bringing the trial to the patient in their home, school or workplace. This can enhance both patient recruitment and retention. Our medical photography team offer an alternative approach by using imagery and video footage within the clinical trial. Imagery can be used in a range of applications concentrated within but not exclusive to dermatological trials.
Pulse Infoframe Inc (Pulse) believes thatcollaboration cures disease and Pulse enablessuch collaboration. A new style of healthcareinformatics company, Pulsebuilds and supports global, healthcareecosystems. It’s solution, healthie™, empowersconsortia of pharmaceutical and medical devicecompanies, researchers, clinicians, advocacygroups and patients, by aggregating informationfrom a variety of sources and then, delivering keyhealthcare insights – real time -- derived fromthese data. For patients with rare diseases, Pulse’sglobal coverage is critical. Already great strideshave been made in characterizing rare diseasesusing Pulse’s global and national registries. Theseinsights help professionals to advance medicalresearch, focus clinical trial recruitment, assistadvocacy groups in their dealings with policymakers and provide real-world evidence. Please visit pulseinfoframe.com
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing. Our global team of 750+ experts — many with PhD or PharmD degrees — work strategically alongside our client partners in medical affairs, health economics and outcomes research (HEOR), market access, and commercial teams across a wide range of therapy areas. The traits that distinguish us and allow us to be leaders in our field include deep scientific knowledge and global understanding, which together create innovative, patient-centric solutions. We have a broad range of healthcare specialist expertise across many Centers of Excellence, enabling us to support our clients through all phases of the product life cycle. And we are united as one flexible organization, harnessing the power of the collective to solve complex challenges.